APA (7th ed.) Citation

Alamer, A., Almutairi, A. R., Halloush, S., Al-jedai, A., Alrashed, A., AlFaifi, M., . . . Alkhatib, N. (2023). Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals. Saudi Pharmaceutical Journal, 31(4), 510. https://doi.org/10.1016/j.jsps.2023.02.003

Chicago Style (17th ed.) Citation

Alamer, Ahmad, et al. "Cost-effectiveness of Favipiravir in Moderately to Severely Ill COVID-19 Patients in the Real-world Setting of Saudi Arabian Pandemic Referral Hospitals." Saudi Pharmaceutical Journal 31, no. 4 (2023): 510. https://doi.org/10.1016/j.jsps.2023.02.003.

MLA (9th ed.) Citation

Alamer, Ahmad, et al. "Cost-effectiveness of Favipiravir in Moderately to Severely Ill COVID-19 Patients in the Real-world Setting of Saudi Arabian Pandemic Referral Hospitals." Saudi Pharmaceutical Journal, vol. 31, no. 4, 2023, p. 510, https://doi.org/10.1016/j.jsps.2023.02.003.